Lopid

Lopid: Uses, Side Effects, Dosage, Interactions

Introduction

Lopid, also known by its generic name gemfibrozil, is a lipid-regulating medication used to treat abnormal blood lipid levels, particularly high triglycerides and low HDL cholesterol. It belongs to a class of drugs called fibrates, which work by reducing the production of triglycerides in the liver and increasing the removal of triglycerides from the blood. Lopid is often prescribed as a preferred medication for patients with very high cholesterol and pancreatitis.

Chemical Composition

The active ingredient in Lopid is gemfibrozil, a fibric acid derivative. Its chemical structure consists of a phenoxy-isobutyric acid linked to a dimethylpentane chain. Gemfibrozil is well absorbed orally, with a bioavailability of approximately 100%. It undergoes hepatic metabolism and is primarily excreted in the urine as glucuronide conjugates.

Mechanism of Action

Lopid works by activating the peroxisome proliferator-activated receptor alpha (PPAR-α), a nuclear receptor that regulates the expression of genes involved in lipid metabolism. Activation of PPAR-α leads to increased production of lipoprotein lipase, an enzyme that breaks down triglycerides in the blood, and decreased production of apolipoprotein C-III, a protein that inhibits triglyceride breakdown. These actions result in a reduction of triglyceride levels and a modest increase in HDL cholesterol levels.

Uses and Indications

Lopid is FDA-approved for the treatment of the following conditions:

Off-label uses of Lopid include the treatment of dyslipidemia in patients with diabetes mellitus and metabolic syndrome.

Dosage and Administration

The recommended dosage of Lopid for adults is 600 mg taken orally twice daily, 30 minutes before morning and evening meals. Dosage adjustments may be necessary for patients with renal impairment or those taking certain medications. Lopid should be used in combination with dietary modifications and other lipid-lowering therapies as prescribed by a healthcare provider.

Side Effects

Common Side Effects

Common side effects of Lopid include:

Rare but Serious Side Effects

Rare but serious side effects of Lopid include:

Warnings and Precautions

Lopid is contraindicated in patients with severe hepatic or renal impairment, preexisting gallbladder disease, and hypersensitivity to gemfibrozil or any component of the formulation. It should be used with caution in elderly patients and those with a history of liver or kidney disease. Concomitant use of Lopid with HMG-CoA reductase inhibitors (statins) may increase the risk of skeletal muscle toxicity and rhabdomyolysis.

Drug Interactions

Lopid may interact with several medications, including:

Patients should inform their healthcare provider about all medications they are taking before starting Lopid therapy.

Alternatives to Lopid

Other medications used to treat high triglycerides and low HDL cholesterol include:

Lifestyle modifications, such as dietary changes, weight loss, and increased physical activity, are also important components of managing dyslipidemia.

Regulation and Approval

Lopid was first approved by the U.S. Food and Drug Administration (FDA) in 1982 for the treatment of very high serum triglyceride levels. It is available by prescription only and is marketed under various brand names worldwide.

Patient Education

Patients taking Lopid should be educated about the importance of adhering to their prescribed dosage, reporting any side effects to their healthcare provider, and maintaining a healthy lifestyle. They should also be aware of the potential for drug interactions and the need for regular monitoring of lipid levels and liver function.

Storage and Handling

Lopid tablets should be stored at room temperature (20-25°C or 68-77°F) in a tightly closed container, protected from light and moisture. The medication should be kept out of reach of children and disposed of properly when expired or no longer needed.

Lopid